PRRT2 and pancreatic neoplasm: RNA-sequencing analysis of pancreatic tumor cell lines derived from the PKC and N4−/−PKC GEMMs revealed that 408 genes were differentially expressed (FDR < 0.05) and Pcsk5 is a potential downstream effector of the Notch4 signaling pathway (P < 0.001).